- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Profiling tyrosine kinase inhibitors as AD therapeutics in a mouse model of AD ; volume:16 ; number:1 ; day:14 ; month:8 ; year:2023 ; pages:1-5 ; date:12.2023
Molecular brain ; 16, Heft 1 (14.8.2023), 1-5, 12.2023
- Creator
-
Lee, Hyun-ju
Hwang, Jeong-Woo
Park, Jin-Hee
Jeong, Yoo Joo
Jang, Ji-Yeong
Hoe, Hyang-Sook
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13041-023-01051-9
- URN
-
urn:nbn:de:101:1-2023110310074309457595
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Hyun-ju
- Hwang, Jeong-Woo
- Park, Jin-Hee
- Jeong, Yoo Joo
- Jang, Ji-Yeong
- Hoe, Hyang-Sook
- SpringerLink (Online service)
Other Objects (12)
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
Editorial: Targeting bruton tyrosine kinase
Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Second-generation inhibitors of Bruton tyrosine kinase
Bcr-Abl tyrosine kinase inhibitors- current status
Targeting tumour microenvironment by tyrosine kinase inhibitor
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
Editorial: Targeting bruton tyrosine kinase
Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Second-generation inhibitors of Bruton tyrosine kinase
Bcr-Abl tyrosine kinase inhibitors- current status
Targeting tumour microenvironment by tyrosine kinase inhibitor
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
Editorial: Targeting bruton tyrosine kinase
Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Second-generation inhibitors of Bruton tyrosine kinase
Bcr-Abl tyrosine kinase inhibitors- current status
Targeting tumour microenvironment by tyrosine kinase inhibitor
Auto-thiophosphorylation activity of Src tyrosine kinase